Authors: Miller, WH Reyno, LM Loewen, GR Huan, S Winquist, E Moore, M Cato, A Jaunakais, D Truglia, JA Matthews, S Dancey, J Eisenhauer, E

Citation: Wh. Miller et al., A phase I-II study of 9-cis retinoic acid and interferon-alpha 2b in patients with advanced renal-cell carcinoma: An NCIC Clinical Trials Group study, ANN ONCOL, 11(11), 2000, pp. 1387-1389

Authors: Small, EJ Meyer, M Marshall, ME Reyno, LM Meyers, FJ Natale, RB Lenehan, PF Chen, L Slichenmyer, WJ Eisenberger, M

Citation: Ej. Small et al., Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: Results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone, J CL ONCOL, 18(7), 2000, pp. 1440-1450

Authors: Irwin, E Arnold, A Whelan, TJ Reyno, LM Cranton, P

Citation: E. Irwin et al., Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer, PAT EDUC C, 37(3), 1999, pp. 283-291